5JM-10281-25023
2 vaccinations
2 coded responses
25 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 600 / IL
- Registered
- 2021-02-08
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-08
Registered in v-safe
-
2021-02-08
Dose 1 — Pfizer-BioNTech
- 2021-02-08
- 2021-02-09
- 2021-02-10
- 2021-02-11
- 2021-02-12
- 2021-02-13
- 2021-02-14
- 2021-02-15
- 2021-02-22
-
2021-03-01
Dose 2 — Pfizer-BioNTech
- 2021-03-01
-
2021-03-02
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-03-03
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, NauseaAdult check-in
- 2021-03-04
- 2021-03-05
-
2021-03-06
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Headache, Muscle or body aches, Fatigue or tiredness, DiarrheaAdult check-in
-
2021-03-07
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-08
- 2021-03-15
- 2021-03-24
- 2021-03-31
- 2021-04-05
- 2021-04-14
-
2021-06-02
Survey response — 3 months, dose 2MedDRA: Sinusitis — Feeling: Good · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Had a sinus infection bacterial treated with antibioticsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-02
Report sent to call center — 3 months, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-30
-
2022-03-03
Survey response — 12 months, dose 2MedDRA: Gastroenteritis viral, Hand-foot-and-mouth disease — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Hand foot and mouth disease. Stomach fluMedDRA releases: 2024-11 · check-in free text available
-
2022-03-03
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-03-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-08 | Pfizer-BioNTech | |
| 2 | 2021-03-01 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-06-02 | Unsuccessful | |
| 2022-03-03 | Unsuccessful |
Free text
Release 8 — 3 months, dose 2
Symptoms: Had a sinus infection bacterial treated with antibiotics
Release 11 — 12 months, dose 2
Symptoms: Hand foot and mouth disease. Stomach flu
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Gastroenteritis viral | · | · | ✓ |
| SD | Hand-foot-and-mouth disease | · | · | ✓ |
| SD | Sinusitis | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release